Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037765 · ClinicalTrials.gov registry record
Gene Modifiers of Cystic Fibrosis Lung Disease
A clinical trial of Cystic Fibrosis and Lung Diseases, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT00037765 is a study of Cystic Fibrosis and Lung Diseases that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 600 participants, above the 176-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (241% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00037765, a study of Cystic Fibrosis and Lung Diseases, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
Conditions Studied
Study Locations (1)
North Carolina
- Marsico Lung Institute - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2001-09 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00037765
The ClinicalTrials.gov registry entry for NCT00037765 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 176-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (241% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00037765 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00037765 about?
NCT00037765 is a clinical study titled "Gene Modifiers of Cystic Fibrosis Lung Disease". The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
What is the current status of trial NCT00037765?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2001-09. Estimated completion is 2027-07.
What conditions does trial NCT00037765 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Lung Diseases.
Who is sponsoring clinical trial NCT00037765?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00037765 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.